Samaneh Kalirai
About Samaneh Kalirai
Samaneh Kalirai is the Associate Director of Field Health Economics and Outcomes Research at Bristol-Myers Squibb in New Jersey, United States.
Current Position at Bristol-Myers Squibb
Samaneh Kalirai currently serves as the Associate Director for Field Health Economics and Outcomes Research at Bristol-Myers Squibb in New Jersey, United States. Since joining the company in May 2018, she has been involved in health economics and outcomes research, leveraging her extensive experience in the pharmaceutical industry to influence healthcare decisions and policy.
Previous Experience at Eli Lilly and Company
Samaneh Kalirai held multiple roles at Eli Lilly and Company, contributing to the organization in various capacities. From 2017 to 2018, she worked as a Research Scientist in US Real World Outcomes Research for seven months in Indianapolis, Indiana. Prior to that, she served as a Consultant Scientist in US Real World Outcomes Research from 2014 to 2017 for three years. She also briefly held the position of Associate Consultant Scientist in US Health Outcomes in 2014. Additionally, she started as a Visiting Scientist Fellow in US Health Outcomes and Health Technology Assessment from 2013 to 2014 for ten months.
Educational Background at Purdue University
Samaneh Kalirai attended Purdue University from 2006 to 2013, where she studied Pharmacy and earned her Doctor of Pharmacy degree. During her time at Purdue, she also worked as a Laboratory Teaching Assistant in 2010, providing support and instruction in the laboratory.
Internship Roles and Early Career Experience
Throughout her career, Samaneh Kalirai gained significant experience through various internship roles. In 2010, she served as a Nuclear Pharmacy Intern at GE Healthcare in Chicago, Illinois. From 2007 to 2012, she worked as a Pharmacy Intern at CVS Pharmacy in Woonsocket, Rhode Island. These roles provided her with the foundational skills and knowledge necessary for her subsequent positions in the pharmaceutical industry.